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1. INTRODUCTION 
It has been known since 1959 that glucagon can 
stimulate adipocyte lipolysis in vitro. With rat 
adipocytes glucagon has been shown to bind spe- 
cifically to whole cells [1], to plasma membranes 
[2], to stimulate adenylate cyclase in ghosts [3] and 
to raise the intracellular content of cyclic AMP [4]. 
A cell-surface hormone receptor coupled to aden- 
ylate cyclase is therefore proposed and it is gener- 
ally assumed that the resultant cyclic AMP pro- 
motes phosphorylation and activation of the hor- 
mone-sensitive lipase by protein kinase action. 
However, glucagon is not generally assigned a sig- 
nificant lipolytic role in mammals in vivo [5]. In 
part, this is because in vitro, high, unphysiological 
concentrations of glucagon are necessary to elicit a 
lipolytic response which, even at its fullest, is con- 
siderably smaller than that seen with maximally 
effective concentrations of other lipolytic agents 
such as adrenaline, noradrenaline, corticotropin or 
theophylline. As discussed below, it is possible that 
this relative ineffectiveness of glucagon in mam- 
malian adipose tissue could result from the use of 
inappropriate conditions for incubation of cells. 
It is now recognised that low concentrations of 
adenosine, acting through 'R-site' adenosine recep- 
tors [6-10], can decrease adipocyte adenylate 
cyclase activity and inhibit hormone-stimulated 
lipolysis. In adipocyte incubations, effects of endo- 
genously-derived a enosine may be controlled and 
minimised by addition of adenosine deaminase 
[11-13]. Work from this laboratory [13,14] has 
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suggested that the lipolytic action of glucagon is 
particularly sensitive to opposition by adenosine. 
This was seen in [14] where lipolysis in adipocytes 
from 24 h-fasted rats was found to be more sensi- 
tive to glucagon (over 10-1°-10 -8 M) than in cells 
from fed animals. However, this change was only 
apparent if low concentrations of adenosine de- 
aminase were present in the cell incubations [14]. It 
was therefore concluded that onset of the fasted 
state might result in a sensitization of adipocytes to 
glucagon, that this change is only seen when at- 
tempts are made to control the endogenous adeno- 
sine level and that there might be a physiological 
role for glucagon in adipose tissue in the fasted 
state [14]. These findings might be explained by 
fasting-induced changes at one or more sites in the 
pathway of activation of lipolysis by glucagon. 
Alternatively, or additionally, fasting-induced 
changes in the effect of adenosine might be in 
volved. As a start to investigating these possibilities 
we have examined the response to glucagon of ad- 
enylate cyclase in plasma membranes from fed 
and fasted rats. It is shown that the response to 
glucagon is enhanced in the fasted state with high 
sensitivity to the hormone being observed. 
2. MATERIALS AND METHODS 
Male Sprague-Dawley rats (160-180 g body 
wt) were bred in the animal colony at University 
College London. Animals were sacrificed at about 
11:00 h. Chemicals were supplied as in [14,15]. In 
addition, Percoll was from Pharmacia, papaverine 
from Sigma and cyclic AMP binding protein was 
prepared from bovine muscle [16]. 
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Adipocytes were isolated after disaggregation f 
epididymal adipose tissues with collagenase [17]. 
For measurement of lipolysis, adipocytes (equiv- 
alent to ~ of those obtained from one rat, -25/zg 
DNA) were incubated in Krebs-Ringer bicarbo- 
nate buffer containing defatted albumin (40 mg/ 
ml), 5 mM glucose and adenosine deaminase (4 
munits/ml), as in [14]. After 1 h the incubations 
were terminated by deproteinisation with HC104 
and glycerol measured [18]. 
Plasma membranes were prepared from the epi- 
didymal adipocytes of 4 rats. The cells were bro- 
ken by agitation on a vortex mixer in 20 ml 0.25 M 
sucrose, 10 mM Tris-HC1, 2 mM EGTA, pH 7.4 
at 0-4°C and rapidly fractionated by the method 
in [19] which employs density-gradient centrifuga- 
tion in Percoll. Finally, the plasma membrane 
preparation was suspended in 1.0 ml 20 mM Tris- 
HCI buffer (pH 7.4) ( -  0.85 mg protein/ml). 
Adenylate cyclase (EC 4.6.1.1) was assayed by a 
modification of the method in [20]. This was per- 
formed at 25°C in 0.2 ml total vol. containing 30 
mM Tris-HCl (pH 7.5), 4 mM MgCI2, defatted al- 
bumin (1 mg/ml), 1 mM ATP, 2 mM creatine 
phosphate, creatine kinase (25 units/ml), adeno- 
sine deaminase (0.4 units/ml), 10 ~M papaverine, 
10 ttM guanylyl-imidodiphosphate (Gpp(NH)p) 
and the indicated concentration of glucagon. The 
reaction was initiated by addition of 20 ~1 plasma 
membranes (10-20 ~g protein) and terminated 
after 20 min by boiling for 3 min followed by cool- 
ing in ice. After brief centrifugation to remove pre- 
cipitated protein, cyclic AMP was measured by a 
binding protein assay [21]. Fresh, non-frozen prep- 
arations of membranes were always used for this 
assay. 
5'-Nucleotidase (EC 3.1.3.5), monoamine ox- 
idase (EC 1.4.3.4), NADP-cytochrome ¢ reductase 
(EC 1.6.2.4) and succinate-cytochrome ¢ reduc- 
tase (EC 1.3.99.1) were assayed as described by 
[22-25], respectively. Measurements of adipocyte 
DNA of protein were as in [26] and [27], respec- 
tively. In all cases, preparations of adipocytes from 
fed and fasted rats were made in parallel on the 
same day. 
3. RESULTS AND DISCUSSION 
Plasma membranes were rapidly prepared using 
Percoll as in [19]. Using adipocytes from fed rats 
this method gave an 8-fold enrichment of 5'-nu- 
cleotidase specific activity over that found in the 
whole homogenate; 13 ___ 2% of the homogenate 5'- 
nucleotidase with spec. act. 34___5 nmol .  min -1 . 
mg protein - l  (mean___SEM of 10 preparations) 
was found in the preparation. The plasma mem- 
brane fraction contained only 2___1% and 5 +__ 2%, 
respectively, of the total homogenate succinate- 
cytochrome c reductase and NADP-cytochrome c 
reductase activities and was therefore judged to be 
reasonably free of inner mitochondrial nd micro- 
somal membranes. The distribution of monoamine 
oxidase in this fractionation procedure was not re- 
ported in [19]. Surprisingly, before the final wash- 
ing, the plasma membrane layer obtained from the 
Percoll gradient contained 45% of the total mono- 
amine (tyramine) oxidase activity and the final 
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Fig.1. Effect of glucagon on adenylate cyclase. Plasma 
membranes were prepared from adipocytes of fed (o) 
and 24 h-fasted rats (.) and assayed for adenylate 
cyclase as in section 2. The values are means__. SEM of 9 
and 8 expt for the fed and fasted states, respectively, 
and are expressed as percentages of the basal activity 
(with 10 ~M Gpp(NH)p). These basal activities were: 
fed, 67+__ 10 and fasted, 88___27 pmol. min -I . mg pro- 
tein-l. ,, **, *** indicate P < 0.05, < 0.02, < 0.01, re- 
spectively, for effects of glucagon vs  the basal state. The 
percentage r sponse differed significantly between the 
fed and fasted states at 10 -12 M (P<0.01), 10 -11 M and 
10 -l° M (both P< 0.05) glucagon. 
358 
Volume 146, number 2 FEBS LETTERS September 1982 
washed plasma membranes still contained 11 + 3% 
of this activity. These results suggest either that 
there is contamination of the plasma membrane 
fraction by mitochondrial outer membrane or that 
adipocyte plasma membrane contains monoamine 
oxidase activity. Perhaps this might not be unrea- 
sonable in adipose tissue with its rich adrenergic 
innervation. 
As in [20] the assay of adenylate cyclase con- 
tained a relatively large amount of adenosine de- 
aminase (400 munits/ml) to minimise inhibitory 
effects of adenosine. Papaverine, which does not 
have adenosine agonist or antagonist actions in 
adipocyte membranes [28] was added to prevent 
cyclic AMP destruction. Under these conditions 
adenylate cyclase assays were linear with time and 
cyclic AMP formation was increased by Gpp- 
(NH)p and glucagon (fig.l) and also (not shown) 
by isoproterenol, noradrenaline, corticotropin and 
fluoride. Fig.1 shows that, in the presence of 
Gpp(NH)p, membranes from fed animals ex- 
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Fig.2. Effect of glucagon on lipolysis. Adipocytes from 
fed (o) and 24 h-fasted (o) rats were incubated for 60 
min and glycerol assayed as in section 2. The values are 
means_.+ SEM of 5 expt and are expressed relative to the 
value at 10 -7 M glucagon. Basal rates of lipolysis in the 
absence of glucagon were: fed, 0.6__.0.3 and fasted, 
1.0__.0.3 /~mol oh -I . mg DNA -1. The cells were taken 
from the same preparations that were used for assay of 
adenylate cyclase (fig. 1). 
hibited a maximum response of adenylate cyclase 
with 10 -7 M glucagon. This represented an approx- 
imate doubling of activity over the basal and may 
be compared with [3] in which the enzyme in 
membranes from fed animals was stimulated 
-2.5-fold by 5 x 10 -6 M glucagon (10 #M 
Gpp(NH)p was present). In the fed state 10 -12 M 
glucagon consistently decreased the cyclase activity 
by -50% (fig.l). The basis of this latter effect is 
unexplained. By contrast, in membranes from fast- 
ed rats, cyclase activity was trebled by 10 -1° M 
glucagon and even 10 -11 M hormone was suffi- 
cient to give more than a doubling of activity. In 
the presence of 10 ~tM Gpp(NH)p there was no 
significant difference between the basal cyclase ac- 
tivities in the fed and fasted states. It was note- 
worthy that 10 /~M Gpp(NH)p alone caused a 
larger percentage increase in cyclase activity in the 
fed state (from 13___6-67+__ 10 pmol, min -1 • mg 
protein - l ,  P<0.001) compared with the fasted 
state (from 48_ 18-88 ___27 pmolo min - l  . mg pro- 
tein-l). 
Plasma glucagon levels in the rat have been re- 
ported over 80-2000 pg/ml; i.e., -2  × 10 °11- 
5 x 10-t0 M [29-31]. Under the conditions used 
here these concentrations are sufficient o activate 
adenylate cyclase in the fasted state, but are un- 
likely to have any appreciable stimulatory effect in 
the fed state. 
In some experiments aliquots of adipocytes were 
also tested for their lipolytic response to glucagon 
(fig.2). Whilst there was reasonable correlation be- 
tween the concentrations of glucagon effective on 
cyclase (fig.l) and lipolysis (fig.2) in the fed state, 
there was considerable disparity between the 
ranges of hormone concentration acting on these 
processes in the fasted state. 
In conclusion, activation of adipocyte adenylate 
cyclase by physiological concentrations of gluca- 
gon is substantially enhanced in the fasted state. It 
is unclear whether this reflects altered properties of 
the glucagon receptor and/or its coupling via a 
guanyl nucleotide-binding protein to the catalytic 
entity of the cyclase. The effect of the hormone on 
intact cells from fasted rats appears to be attenu- 
ated. At present it is unclear whether in vivo the 
adenylate cyclase (and hence lipolysis) is more re- 
sponsive to glucagon after fasting, in which case 
the attenuation of response presumably is an ar- 
tefact of the cell incubation system. Alternatively, 
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attenuation of the glucagon response might occur 
in vivo, in which case sensitization of the cyclase 
by fasting makes little physiological sense. 
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